Medical devices, healthcare technology and the business of care
PMA approval · P010032

GENESIS AND EON FAMILY NEUROSTIMULATION (IPG) SYSTEMS

ABBOTT MEDICAL · Decision date Nov 21, 2001

MEDTECHLEDGER EXPLANATIONP010032

What did the FDA approve?

This FDA record is an approval for the Genesis neurostimulation (IPG) system, not a supplement action. The record names the system components as the Model 3608 pulse generator, Model 3850 patient programmer, Model 1232 programming wand, and Model 1210 patient magnet.

The stated scope is limited to use as an aid in managing chronic intractable pain of the trunk and/or limbs, including pain associated with failed back surgery syndrome, intractable low back pain, and leg pain. The record does not supply new study data, performance claims, or technical changes beyond those listed components and the reported indication.

FDA approval order statement

APPROVAL FOR THE GENESIS NEUROSTIMULATION (IPG) SYSTEM. THE SYSTEM INCLUDES THE FOLLOWING COMPONENTS: THE MODEL 3608 PULSE GENERATOR, THE MODEL 3850 PATIENT PROGRAMMER, THE MODEL 1232 PROGRAMMING WAND AND THE MODEL 1210 PATIENT MAGNET. THE DEVICE IS INDICATED AS AN AID IN THE MANAGEMENT OF CHRONIC INTRACTABLE PAIN OF THE TRUNK AND/OR LIMBS, INCLUDING UNILATERAL OR BILATERAL PAIN ASSOCIATED WITH FAILED BACK SURGERY SYNDROME, INTRACTABLE LOW BACK PAIN AND LEG PAIN.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Nov 21, 2001

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010032
Regulatory pathway
Premarket approval application
Product code
LGW
Decision code
APPR
Decision date
Nov 21, 2001
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P010032 received

    Application receipt date recorded by FDA.

  2. P010032 · FDA decision

    APPR

  3. P010032/S261 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  4. P010032/S251 · Related supplement

    Quattrode; Octrode; Penta; Lamitrode; Tripole; TriCentrus Lead Extensions

  5. P010032/S260 · Related supplement

    Proclaim family of SCS IPG

  6. P010032/S265 · Related supplement

    Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generator

  7. P010032/S262 · Related supplement

    Spinal Cord Stimulation (SCS) External Pulse Generator (EPG)

  8. P010032/S264 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  9. P010032/S266 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P010032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010032

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Preston Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records